WuXi AppTec Co., Ltd.
603259
Peringkat dalam Saham
#458
WuXi AppTec Co., Ltd., an investment holding company, provides research and... WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally. The company operates through WuXi Chemistry, WuXi Testing, WuXi Biology, and Others segments. It offers contract research, development, and manufacturing organization (CDRMO) services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions which support stand-alone and integrated projects from target discovery to candidate selection and into the clinic. The company also provides laboratory testing services, such as toxicology, DMPK, and bioanalytical services; clinical contract research organization services, including Phase I to Phase IV clinical development services, and bioequivalence for products including pharmaceuticals and biologics; and site management organization, patient recruitment, site start-up, and academic research organization. In addition, it offers services for biology; CDRMO platform for small molecules, oligonucleotides, and peptides; drug research and development testing; and clinical research services. WuXi AppTec Co., Ltd. was founded in 2000 and is headquartered in Shanghai, the People’s Republic of China.
Harga Saham
$21.16
Kapitalisasi Pasar
$52.34B
Perubahan (1 hari)
-4.10%
Perubahan (1 tahun)
49.45%
Negara
CN
Perdagangan WuXi AppTec Co., Ltd. (603259)
Kategori
Healthcare
Rasio P/E untuk WuXi AppTec Co., Ltd. (603259)
Rasio P/E per October 2026 TTM: 18.69
Menurut laporan keuangan dan harga saham terbaru dari WuXi AppTec Co., Ltd., rasio P/E saat ini (TTM) adalah 18.69. Pada akhir 2024, perusahaan memiliki rasio P/E sebesar 16.78.
Riwayat rasio P/E untuk WuXi AppTec Co., Ltd. dari 2014 hingga 2026
Rasio P/E di akhir setiap tahun
| Tahun | Rasio P/E | Mengubah |
|---|---|---|
| 2026 (TTM) | 18.69 | 38.56% |
| 2025 | 13.49 | -19.62% |
| 2024 | 16.78 | -24.58% |
| 2023 | 22.25 | -17.31% |
| 2022 | 26.91 | -60.29% |
| 2021 | 67.76 | -36.12% |
| 2020 | 106.08 | 31.29% |
| 2019 | 80.80 | 149.99% |
| 2018 | 32.32 | 36.17% |
| 2017 | 23.74 | -17.35% |
| 2016 | 28.72 | -63.98% |
| 2015 | 79.73 | 30.77% |
| 2014 | 60.97 | 0.00% |
Rasio P/E untuk perusahaan serupa atau pesaing
| Perusahaan | Rasio P/E | Perbedaan Rasio P/E | Negara |
|---|---|---|---|
| 36.15 | 93.43% |
US
|
|
| 39.77 | 112.79% |
US
|
|
| -290.26 | -1,652.86% |
US
|
|
| 34.92 | 86.84% |
US
|
|
| 32.24 | 72.51% |
US
|
Bagaimana cara membaca P/E ratio?
Rasio Harga/Laba (P/E) mengukur hubungan antara harga saham perusahaan dan laba per sahamnya.
P/E yang rendah namun positif menunjukkan perusahaan dengan laba tinggi dibandingkan valuasinya saat ini dan mungkin dianggap undervalued. P/E negatif tinggi (mendekati 0) menunjukkan perusahaan yang mengalami kerugian besar.
Perusahaan dengan P/E di atas 30 atau negatif umumnya dianggap sebagai "saham pertumbuhan", artinya investor mengharapkan pertumbuhan atau keuntungan di masa depan.
Perusahaan dengan P/E positif di bawah 10 dianggap sebagai "saham bernilai", artinya perusahaan sudah sangat menguntungkan dan pertumbuhannya kemungkinan tidak besar.